SEC Form 4 · accession 0001193125-26-388302
KESTRA MEDICAL TECHNOLOGIES, LTD. · KMTS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Conor Hanley
Director
Period of report
Sep 8, 2026
Accepted (ET)
Sep 10, 2026 · 8:28 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001877184
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF2 | Sep 8, 2026 | S | 5,694 | $25.2509 | D | 6,272 | D | |
| Common SharesF3 | Sep 9, 2026 | A | 7,217 | — | A | 13,489 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
- F2The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $24.9100 to $25.5100. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
- F3The reported securities represent restricted stock units which each entitle the reporting person to receive one common share of the Issuer. The restricted stock units will vest on September 9, 2027, subject to the reporting person's continued service through such date.
Remarks
Exhibit 24.1 - Power of Attorney